Century Capital Management’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
Other funds holding IPXL
MC
FCM
Century Capital Management's IPXL Position: Q2 2017 in Review
Century Capital Management reduced its Impax Laboratories, Inc. (IPXL) stake by 19% in Q2 2017, selling an estimated $703K and leaving 203,138 shares worth $3.27M. The position accounts for 0.56% of the portfolio, ranked #63.
Century Capital Management first reported a position in IPXL in Q1 2017 and has held it in 2 quarters since. 172 funds tracked by Wall St. Rank hold IPXL as of Q2 2017.
- Century Capital Management held 203,138 shares of Impax Laboratories, Inc. worth $3.27M as of Q2 2017.
- Century Capital Management sold 47,578 Impax Laboratories, Inc. shares in Q2 2017, an estimated $703K.
- Impax Laboratories, Inc. made up 0.56% of Century Capital Management's portfolio in Q2 2017, its #63 holding.
- Century Capital Management first reported a position in Impax Laboratories, Inc. in Q1 2017 and has held it in 2 quarters since.
- 172 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2017.
Based on Century Capital Management's 13F filing for Q2 2017, filed 10 Aug 2017.